Dr. Sudip K. Das is Professor of Pharmaceutics at the College of Pharmacy & Health Sciences, Butler University, Indianapolis, IN, where he also served as the chair of the Department of Pharmaceutical Sciences from 2004-09. After obtaining an undergraduate degree in pharmacy and MPharm and PhD in Pharmaceutics from India, Dr. Das pursued postgraduate training as a UNIDO scholar in pharmaceutical technology at the State University of Gent, Belgium. He continued postdoctoral training at The University of Queensland, Australia, following which he accepted a faculty position at Memorial University of Newfoundland, Canada. Before joining Butler, Dr. Das held faculty positions in pharmacy colleges at Nova Southeastern University and Idaho State University. Dr. Das has over twenty years of teaching experience in the professional pharmacy and graduate programs in the USA and Canada. He has supervised a number of postdoctoral, graduate and undergraduate research students, and was the key faculty responsible for the revitalization of the graduate program and research infrastructure in pharmaceutical sciences at Butler University Dr. Das has over 150 research publications, review articles, patents, proceedings, conference presentations, and book chapters, is a recipient of multiple awards/honors, and has secured extramural research funding from NIH, PDA, etc., and the pharmaceutical industry. Dr. Das has been an active member of AACP since 1994, where he became an AACP Leadership Fellow (2005), and served as the chair-elect, chair and immediate past chair of the Teachers of Pharmaceutics Section (2006-09). As the section chair, he strongly advocated the professional growth of the pharmaceutics faculty workforce, and the development of contemporary pharmaceutics curricula. From 2008-11, Dr. Das served as the founding chair and immediate past chair of the AACP Council of Sections, where he led the task of developing the mission and goals of the new council, and created various task forces supporting the missions of the AACP sections. He has also served on the AACP Board of Directors (2008-11), AACP Research & Graduate Affairs and the Bylaws and Policy Development Committees, along with various AACP Task Forces. Dr. Das is also an active member of AAPS (since 1991) and CRS (Controlled Release Society, since 1987). He has served on many committees of the PDD/PPB and BIOTEC sections of AAPS. Since 2004, he has served on several study sections for the NIH - Center for Scientific Review and continues to serve on the editorial boards of AJPE and Therapeutic Delivery.

His current research involves targeted delivery of siRNA and nano-composites for the treatment of cancer and neurodegenerative diseases.